ABL Bio Inc. (KOSDAQ:298380)
South Korea flag South Korea · Delayed Price · Currency is KRW
194,000
+2,900 (1.52%)
At close: Feb 27, 2026

ABL Bio Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21
10,727,7571,443,6301,178,1561,099,1291,041,424
Market Cap Growth
498.89%22.53%7.19%5.54%-
Enterprise Value
10,643,9821,335,3371,126,3981,038,936-
Last Close Price
194000.0029900.0024600.0023000.0022100.00
PE Ratio
---342.55-
PS Ratio
121.3043.2217.9716.33195.31
PB Ratio
58.878.6315.9015.8118.61
P/TBV Ratio
59.818.9116.4716.4319.50
P/FCF Ratio
---15.69-
P/OCF Ratio
---15.24-
EV/Sales Ratio
120.3639.9817.1815.44-
EV/EBITDA Ratio
---321.37-
EV/EBIT Ratio
---1144.20-
EV/FCF Ratio
-197.00--14.83-
Debt / Equity Ratio
0.240.260.590.600.01
Debt / EBITDA Ratio
---12.94-
Debt / FCF Ratio
---0.60-
Net Debt / Equity Ratio
-0.46-0.58-0.37-0.52-0.77
Net Debt / EBITDA Ratio
3.131.72996.51-11.280.88
Net Debt / FCF Ratio
1.551.250.80-0.521.03
Asset Turnover
0.370.170.380.54-
Quick Ratio
2.492.241.711.095.01
Current Ratio
2.532.281.811.125.20
Return on Equity (ROE)
-15.80%-46.01%-3.69%5.12%-
Return on Assets (ROA)
-7.78%-18.93%-0.95%0.45%-
Return on Capital Employed (ROCE)
-16.30%-35.20%-2.20%0.80%-90.30%
Earnings Yield
-0.27%-3.85%-0.22%0.29%-4.18%
FCF Yield
-0.50%-5.43%-2.90%6.38%-4.02%
Buyback Yield / Dilution
-3.78%-0.37%-0.58%-1.27%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.